DANIELLE TASHAKORI: Open Payments
NPI 1518217231 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 36 payments from 17 companies in 2025. Trend: 2023 $942 · 2024 $742 · 2025 $884
Food & beverage: $771Education: $113
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $188 |
| UCB, Inc. | 4 | $139 |
| ABBVIE INC. | 4 | $104 |
| LEO Pharma Inc. | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Botanix SB Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Organon LLC | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $26 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ADBRY, ANZUPGO, SOFDRA, TALTZ, DUPIXENT.
Industry payments across NC — which companies pay providers there.
